Wholesale of pharmaceutical and medical goods
DNE PHARMA AS
Revenue 2024
NOK 62.3m
Operating profit
NOK 11.3m
Equity
NOK 53.4m
Incorporated
2007
Employees
5
Share capital
NOK 142,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 62.3m | |
| Total operating costs | 51.0m | |
| Operating profit (EBIT) | 11.3m | |
| Net financial items | 102k | |
| Profit for the year | 8.9m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 96.5m | |
| of which current assets | 52.8m | |
| Equity | 53.4m | |
| Total liabilities | 43.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.